Whole and 2% milk has been banned from school meals since 2012 Associated PressApril 1, 2025 Mexico Bans Junk Food Sales in Schools in Its Latest Salvo Against Child Obesity Mexico says a government-sponsored junk food ban in schools has taken effect as the country tries to tackle one of th...
German Finance Minister: Agreement With US Is Still Preferred Option in Tariff Row ReutersApril 24, 2025 Morning Bid: Dour Sentiment Readings Threaten Relief Rally ReutersApril 24, 2025 European Car Sales Rise in March, Tesla Drops 28.2%
Verify registration and listing status from the FDA Website >>>US FDA Establishment Registration FeeThe US Federal government’s fiscal year begins on October 1 and ends on September 30. Thus, the annual FDA registration fee is to be paid between October and December 31st. FDA Establishment Reg...
FDA outlines measures to combat counterfeiting. (US Food and Drug Administration).(Government)
FDA-approved pharmacotherapy agents have moderate benefits for reducing relapse and increasing retention in treatment in adults with opioid use disorders Adequate evidence that psychosocial interventions have moderate benefits for increasing abstinence from or reducing unhealthy drug use; effects may be ...
2. US Government Accountability Office. Investigational new drugs—FDA has taken steps to improve expanded access program but should further clarify how adverse events data are used. https://www.gao.gov/assets/690/685727.pdf. Published July 2017. Accessed October 9, 2017. 3. Treatment IND or...
The US Government has signed an agreement with Pfizer to procure ten million courses of the company’s Covid-19 oral antiviral candidate, Paxlovid (PF-07321332; ritonavir), for $5.29bn, on obtaining the US Food and Drug Administration (FDA) authorisation. ...
IPA is actively involved in advising the government on matters of professional importance. IPA is affiliated with international pharma associations like FIP, FAPA, CPA, AAPS, AAiPS, IPSF and is working with international bodies such as WHO and WHPA for carrying out various collaborative professional...
US FDA PERSPECTIVE (BY SAU L. LEE AND BHAWANA SALUJA) A EUROPEAN PERSPECTIVE ON ORALLY INHALED AND NASAL “GENERIC / HYBRID” PRODUCTS (BY ALFREDO GARCIA ARIETA) ANVISA PERSPECTIVE (BY GUSTAVO MENDES LIMA SANTOS) CHINA’S PERSPECTIVE (BY YING LI, SARAH LU, AND SHUGUANG HOU) INDIAN PERSPECTI...
The President said that the White House is “trying to expedite things,” along with the FDA, to get therapeutics “immediately into those hospitals or wherever the people are located.” “What big news it is medically,” he said. “We are so far ahead of where you would normally be jus...